Essex, United Kingdom

Joseph Leo Mckenna

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Soley Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Leo Mckenna. Retrieved from https://idiyas.com/inventor/joseph-leo-mckenna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Leo Mckenna: Innovator in Pharmaceutical Modulators

Introduction

Joseph Leo Mckenna is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modulators for the treatment of diseases. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Joseph Leo Mckenna holds a patent for "Phthalazinone based modulators for the treatment of disease." This patent includes compounds and pharmaceutical compositions of Formula (II). His work in this area demonstrates a commitment to finding effective solutions for various health conditions.

Career Highlights

Throughout his career, Mckenna has been associated with Soley Therapeutics, Inc., where he has played a crucial role in research and development. His contributions have been instrumental in the advancement of therapeutic options available in the market.

Collaborations

Mckenna has collaborated with talented individuals such as Nadia Mamoona Ahmad and Christopher Charles Rennie. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Joseph Leo Mckenna is a distinguished inventor whose work in pharmaceutical modulators has the potential to impact the treatment of diseases significantly. His dedication to innovation and collaboration continues to drive advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…